Navigation Links
leViv Launches First Meal Programs Specifically Designed for Taste and Health
Date:7/9/2008

BETHESDA, Md., July 9 /PRNewswire/ -- leViv, Inc. (http://www.leViv.com), the only company focused exclusively on nutrition and lifestyle programs for individual health, has launched five innovative programs today. The new programs include 28-days of delicious, delivered food (2 meals and 2 snacks per day -- over 110 items in every order), online recipes, health strategies, online communities, educational resources, professional advice, news, health information and more.

"The idea was born from a real problem; helping my parents sort through all of the confusing nutrition and lifestyle information in the market today. They asked, 'Should we eat tomatoes? Drink red wine? Eat high fat or low carb? Eat meat or avoid meat? Take flax or avoid wheat?'" said CEO and founder, Mitchell Goldsteen. "Given the lack of quality options actually focused on health and not simply fad weight loss, we decided it was time to create a significantly different and significantly better option."

"We believe our consumers want change. They want to feel better. They demand and deserve quality. Our product is healthier than any other program, has more natural antioxidants, uses better ingredients and is more affordable than other programs. We are working hard to create a new brand -- a brand driven by our passion, our skills, the best available information and a healthy dose of sleepless nights," said Goldsteen. leViv offers the first comprehensive programs that are designed to provide adults concerned with type II diabetes, cardiovascular disease, chronic kidney disease, and prostate cancer with a convenient, nutritious, and delicious monthly program that aims to affordably improve health. leViv programs are also perfect for all adults looking to live healthfully. While weight loss is not leViv's primary objective, it is an added benefit of leViv's balanced and unique approach.

leViv programs deliver exceptional tast
'/>"/>

SOURCE leViv, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...habits being replaced by Western lifestyles and di...ral indigenous populations across Asia, the Pacif...s. Professor Martin Silink, head of the Brussels-... said that indigenous people appeared to have a gr...
...jectable anti-TNF therapy that has FDA approval fo...ven effective in children with juvenile rheumatoid... week at the American College of Rheumatology Annu...DC. The immunosuppressant adalimumab, currently u...
...udy conducted by cardiologists of Duke University ...an be used as a conventional method for detecting ...system disorder sarcoidosis, who are at higher ris...ng MRI to discover minute areas of heart damage be...
...rom dengue so far, Ranchi registered its first dea...ngh, a public relations officer of the Central Min...ndia Ltd (CIL) undertaking, died of dengue Sunday ...he Guru Nanak Hospital here Saturday. The doctor...
Other Medicine News:Health News:Diabetes- a Threat to Several Indigenous Populations 2Health News:Adalimumab Proves Effective for Children with Juvenile Rheumatoid Arthritis 2Health News:MRI Detects Early Heart Damages In Patients 2Health News:MRI Detects Early Heart Damages In Patients 3
(Date:9/4/2008)...n for the treatment of Acute Myeloid .... 4 /- Celator Pharmaceuticals today,... (FDA) has granted orphan,drug designation to CPX-...or the treatment of Acute Myeloid Leukemia (AML).,...ndomized Phase 2,studies with CPX-351. The first P...
(Date:9/4/2008)...al-time PCR testing for the diagnostic ...pt. 4 /- The U.S. Food & Drug,Adminis...an(R) HBV Test,the first assay for quantitating H... uses Roche,s real-time PCR technology to quantify...s blood. Doctors may use viral load,testing result...
(Date:9/4/2008)...an-Gynecologists States UFE Meets Level,A Evidence...nterventional,Radiology Treatment Is Safe, Effecti...X, Va., Sept. 4 /PRNewswire-USNewswire/ -- The Soc...ization of nearly 4,500 doctors,scientists and al...ealth,care through minimally invasive treatment in...
(Date:9/4/2008)...omen at More Than 100 Sites in the U.S., ANN ARBO...ticals, a,privately-held biopharmaceutical company...ompounds to treat endocrine, metabolic and,cardiov...tiated a second,Phase 3 clinical trial of Ophena(T...ee oral therapy in development for the treatment o...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Model offers new understanding of cell signaling 15005 1Model offers new understanding of cell signaling 15005 2Spring Ankle Sprain Prevention Tips 15003 1Spring Ankle Sprain Prevention Tips 15003 2Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 1Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 2Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 3Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 4Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 5Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 6Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 7Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 8Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 9Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 10Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 11Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 12Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 13Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 14U S Patent Office Confirms Validity of Osteotechs U S Patent No 5 676 146 4150 1U S Patent Office Confirms Validity of Osteotechs U S Patent No 5 676 146 4150 2
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures.
...of the PARAHISIAN catheter, combines an octapolar ...es, which permits the use of only one catheter for...is bundle electrograms. The "two catheters in one"...single venipuncture. The disadvantages of using tw...
Torqr Quadripolar Braided Shaft Fixed Curve. The Medtronic CardioRhythm Torqr Catheter is intended for use in diagnostic electrophysiologic procedures. The catheter is designed for recording intrac
Xtrem Dynamic is a line of steerable diagnosis catheters with micro handle. These catheters have been designed to provide pacing and recording during invasive electrophysiology procedures.
Medicine Products: